symbol,statement_type,period_end,line_item,value
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Normalized EBITDA,1446507000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,345458000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,5442226000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,EBITDA,1446507000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,EBIT,1101049000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Interest Income,-145401000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense,145401000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Interest Income,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Normalized Income,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Total Expenses,6651290000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Diluted Average Shares,50715929.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Basic Average Shares,50715929.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Diluted EPS,19.65
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Basic EPS,19.65
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,996568000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Tax Provision,-1935000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Pretax Income,955648000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,-1466920000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Other Special Charges,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Write Off,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-145401000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,145401000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Operating Income,2567969000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Operating Expense,1209064000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Other Operating Expenses,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,345458000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Amortization,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,345458000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Research And Development,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Selling General And Administration,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Gross Profit,3777033000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Cost Of Revenue,5442226000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Total Revenue,9219259000.0
ORCHPHARMA.NS,income,2025-03-31 00:00:00,Operating Revenue,9219259000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Normalized EBITDA,1415368000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items,-6511000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-6511000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,332371000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,4844591000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,EBITDA,1415368000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,EBIT,1082997000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Interest Income,-163545000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense,163545000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Interest Income,163481000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Normalized Income,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Total Expenses,5873379000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,33417000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Diluted Average Shares,48355981.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Basic Average Shares,48355981.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Diluted EPS,19.06
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Basic EPS,19.06
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,0.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,921665000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Tax Provision,-31191000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Pretax Income,919452000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,-1237306000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Special Income Charges,-6511000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Other Special Charges,1884000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Write Off,4627000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-163545000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,3811000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,163545000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,163481000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Operating Income,2320303000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Operating Expense,1028788000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Other Operating Expenses,898497000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,332371000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Amortization,11306000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,332371000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Research And Development,70937000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Selling General And Administration,322827000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,238563000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,General And Administrative Expense,84264000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,33417000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Gross Profit,3349091000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Cost Of Revenue,4844591000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Total Revenue,8193682000.0
ORCHPHARMA.NS,income,2024-03-31 00:00:00,Operating Revenue,8193682000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1022590000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items,400004000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,400004000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,530934000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,547868000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,3971760000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,EBITDA,1422594000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,EBIT,874726000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Interest Income,-322842000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense,322257000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Interest Income,6180000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Normalized Income,130930000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,463183000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Total Expenses,6362294000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,10160000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Diluted Average Shares,40816400.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Basic Average Shares,40816400.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Diluted EPS,11.35
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Basic EPS,11.35
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,463183000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,463183000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income,463183000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,463183000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,-67751000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,530934000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Tax Provision,0.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Pretax Income,552469000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,126602000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Special Income Charges,399850000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Other Special Charges,-399850000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Write Off,0.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-322842000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,6765000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,322257000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,6180000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Operating Income,296690000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Operating Expense,2390534000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Other Operating Expenses,859732000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,547868000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Amortization,78000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,547790000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Research And Development,63621000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Selling General And Administration,231228000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,143363000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,General And Administrative Expense,87865000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,10160000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Gross Profit,2687224000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Cost Of Revenue,3971760000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Total Revenue,6658984000.0
ORCHPHARMA.NS,income,2023-03-31 00:00:00,Operating Revenue,6658984000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Normalized EBITDA,616248000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items,5128000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,5128000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-604214000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,870246000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,3262850000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,EBITDA,621376000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,EBIT,-248870000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Interest Income,-330372000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense,320117000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Interest Income,4188000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Normalized Income,-609342000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-19512000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Total Expenses,5920030000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,15809000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Diluted Average Shares,40816400.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Basic Average Shares,40816400.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Diluted EPS,-0.48
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Basic EPS,-0.48
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-19512000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-19512000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income,-19512000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-19512000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,584702000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-604214000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Tax Provision,0.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Pretax Income,-568987000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,4895000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Special Income Charges,4000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Other Special Charges,-4000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Write Off,
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-330372000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,14443000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,320117000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,4188000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Operating Income,-324456000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Operating Expense,2657180000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Other Operating Expenses,747415000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,870246000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Amortization,313000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,869933000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Research And Development,66263000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Selling General And Administration,309031000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,222617000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,General And Administrative Expense,86414000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,15809000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Gross Profit,2332724000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Cost Of Revenue,3262850000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Total Revenue,5595574000.0
ORCHPHARMA.NS,income,2022-03-31 00:00:00,Operating Revenue,5595574000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,EBITDA,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,EBIT,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Interest Income,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Interest Income,7326000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Normalized Income,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Total Expenses,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,15061000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Basic Average Shares,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Diluted EPS,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Basic EPS,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Tax Provision,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Pretax Income,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Special Income Charges,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Other Special Charges,650000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Write Off,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,8708000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,7326000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Operating Income,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Operating Expense,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Other Operating Expenses,498681000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Amortization,318000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Research And Development,48097000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Selling General And Administration,263539000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,134550000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,General And Administrative Expense,128989000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,15061000.0
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Gross Profit,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Total Revenue,
ORCHPHARMA.NS,income,2021-03-31 00:00:00,Operating Revenue,
